Stockhouse Podcasts

Iron Ore & Vanadium in Quebec: Who’s Driving BOTH Markets?

One of the world’s least known metals also happens to be of immense importance and is likely to become even more so as renewable energies catch up with and, eventually, eclipse fossil fuels. If you don’t know much about vanadium, you’re not alone.
About six months ago, a Canadian mineral exploration Company published a Preliminary Economic Assessment outlining annual production of approximately five million tonnes of high-grade, low-impurity, iron concentrate…grading roughly 65 percent iron along with 0.6 percent vanadium penta-oxide per tonne of concentrate from its Mont Sorcier Iron and Vanadium Projects…located in the historic mining jurisdiction near Chibougamau Québec.
Vanadium One Iron Corp. (TSX-V: VONE, OTC: VDMRF, Forum) started its 2020 drill program at Mont Sorcier targeting to expand the current resource base and deliver a new Mineral Resource Estimate (MRE) by Q1 2021. This drill program aims to increase the current resources to a minimum of between 900 million to 1.1 billion tonnes at grades of between 24 to 34 percent magnetite. Additionally, these results are intended to enhance the value presented in the PEA.
In this intriguing podcast, Stockhouse Media’s Dave Jackson was joined by Company President and CEO, Cliff Hale-Sanders, to discuss Vanadium One’s latest drill program at Mont Sorcier in Quebec, vanadium’s key attributes and markets, and the Company’s unique dual resource business model.

The Company That’s Delivering Safe, Evidence-Based Psychedelic-Assisted Psychotherapies

Stockhouse investors who are dialed into the not-only nascent but now, pardon the pun, mushrooming psychedelics sector are likely familiar with a mental health and wellness company “centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies.” In short, an entirely new way of successfully addressing and treating the growing prevalence of mental health issues and desire for greater wellness as a whole.
 
Numinus Wellness Inc. (NUMI) (TSX-V.NUMI, OTCMKTS: LKYSF, Forum) is a Company that is “creating an ecosystem of health solutions” aimed at advancing psychedelic laboratory testing, therapy, and research delivering psychedelic-assisted psychotherapies and other transformative and supportive health solutions. Also known as ‘magic mushrooms’, psilocybin and its assisted psychotherapy are currently being studied as a treatment for a wide range of mental health conditions including depression, anxiety, and substance use disorders.
 
The Company says its vertically-integrated ecosystem positions it to be a first-in-market, trusted leader in the delivery of psychedelic-assisted psychotherapies when regulated.
From product development and supply, to analytics and testing, to clinical protocol development and implementation science in partnership with leading research organizations, the unique ecosystem approach allows Numinus to ensure quality control and best-in-class delivery with steady revenue streams to support its developments.
In this lively and informative podcast, Stockhouse Media’s Dave Jackson reached out the Company Chairman & CEO Payton Nyquvest to discuss a myriad of timely and intriguing topics that investors need to know about this burgeoning market.

Stockhouse Podcast - ImaginAR

 
Imagine A-R Incorporated  is a developer of augmented reality, (AR), platforms that are proving to be transformative for how we engage - and experience - immersive digital marketing campaigns. 
This Canadian AR Company recently signed a five-year partnership with the National Football League’s Alumni Academy to create a custom platform for the Academy to engage and activate players, coaches, and sponsors to connect with football fans around the globe. 
Adding to this news, the Company just signed a two-year partnership agreement with Valencia CF of Spain’s La Liga league, one of the biggest soccer clubs in the world with seven million social media followers. 
There is a lot to digest here, and we are joined by Imagine AR CEO Allen Paul Silverrstieen to find out more …. 

A ‘Barrier’ to Better Health

The blood-brain barrier plays an essential role in protecting the brain from blood-borne disease. But is also one of medicine’s great paradoxes – a system designed to protect the most sensitive region of the body but, in turn, ends up actively inhibiting the ability to treat disease within that sensitive region.
Bioasis Technologies Inc. (TSX-V.BTI, OTC:BIOAF, Forum) is a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain. The Company’s goal is to generate shareholder value by developing and commercializing its proprietary brain delivery technology – XB3 – to make life-saving drugs brain-penetrant and deliver those drugs at a therapeutically relevant dose.
In this intriguing podcast, Stockhouse Media’s Dave Jackson was joined by CEO Dr. Deborah Rathjen to talk more about the Company’s amazing XB3 platform, its landmark partnership with the Chiesi Global Rare Diseases Group, and all the things Bioasis shareholders and investors should be watching for in the upcoming months.

A Psychedelic & Nutraceutical Opportunity: A Boost for the Brain and Your Portfolio

A psilocybin mushroom, also known as a magic mushroom, offers infinite medical and scientific potential…from cognitive flexibility to potentially addressing clinical depression and eating disorders. There’s a lot we still don’t know, but one Canadian company is advancing research to find out. 
Toronto ON-based Cybin Corporation is a medicinal mushroom life sciences company that views psychedelic substances derived from mushrooms as “boosters for the brain” that can potentially rebuild pathways and break negative patterns all while looking at non-psychedelic medical mushroom extracts as the next wave of nutraceuticals that can optimize overall health. 
In this fascinating podcast, Stockhouse Media’s Dave Jackson was joined by Cybin’s newly-minted CEO, Doug Drysdale, to talk about the company’s innovative research into psychedelic mental health sciences, their unique product portfolio, upcoming public listing, and much more.

Profiting from Protection: The Power of Permission-Based Partner Programs

Savvy investors know that lot of smart money is now funnelling into forward-thinking companies that are fulfilling an immediate need to provide real world solutions to identity fraud and creating value through data validation.
 
Now, an innovative, Toronto-based company is making real things happen to protect consumers, companies, and capital.
 
KABN Systems (CSE.KABN, OTCMKTS: TRWRF, Forum) focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from the use of their online identity. KABN’s propriety technology suite includes four key products – KABN ID, Liquid Avatar, KABN Card, and KABN KASH. The company provides its products and services at no cost to consumers and generates revenues through permission-based partner programs.
 
In this extremely informative podcast, Stockhouse’s Dave Jackson was joined by KABN’s President, Co-Founder, and Director David Lucatch. Mr. Lucatch has spent more almost 35 years in the international marketing arena and over 25 years of that developing technologies and taking them to market. Prior to co-founding KABN, David held senior management posts and directorships at both private and public technology and media firms.
 
The Company believes that ownership of identity is a basic human right and individuals should be the primary beneficiary of any use of their identity. 

A Major Helium Play Readies to Make its Stock Even More Valuable

One of the largest helium property holders in North America is making headlines with big news and its current market capitalization is attracting the attention of the investment community.
 
Royal Helium Ltd. (TSX-V.RHC, Forum) is focused on the exploration and development of primary helium production and has approximately 400,000 hectares of prospective helium land in south western and south-central Saskatchewan held under lease, permit or application.
 
Trading on the TSX Venture Exchange under the symbol R-H-C, the Company has been busy lately. It recently received the final analysis from the triaxial magnetic survey conducted over its Climax helium permit lands.
 
In this exclusive Stockhouse podcast, Royal Helium’s Chairman, President, and Chief Executive Officer, Andrew Davidson, took time out of his busy schedule to sit down with Stockhouse Editorial’s Dave Jackson to tell us more about where the Company, and the market, are headed.

Hire Tech. Interview with CEO Simon Dealy